Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review

Microalgae are photoautotrophic microorganisms that comprise species from several phyla. Microalgae are promising in producing a variety of products, including food, feed supplements, chemicals, and biofuels. Medicinal supplements derived from microalgae are of a significant market in which compound...

Full description

Bibliographic Details
Main Authors: Tengku Ibrahim, Tengku Nilam Baizura, Feisal, Nur Azalina Suzianti, Kamaludin, Noor Haziqah, Cheah, Wai Yan, How, Vivien, Bhatnagar, Amit, Ma, Zengling, Show, Pau Loke
Format: Article
Published: Elsevier 2023
Online Access:http://psasir.upm.edu.my/id/eprint/106890/
_version_ 1848864844807143424
author Tengku Ibrahim, Tengku Nilam Baizura
Feisal, Nur Azalina Suzianti
Kamaludin, Noor Haziqah
Cheah, Wai Yan
How, Vivien
Bhatnagar, Amit
Ma, Zengling
Show, Pau Loke
author_facet Tengku Ibrahim, Tengku Nilam Baizura
Feisal, Nur Azalina Suzianti
Kamaludin, Noor Haziqah
Cheah, Wai Yan
How, Vivien
Bhatnagar, Amit
Ma, Zengling
Show, Pau Loke
author_sort Tengku Ibrahim, Tengku Nilam Baizura
building UPM Institutional Repository
collection Online Access
description Microalgae are photoautotrophic microorganisms that comprise species from several phyla. Microalgae are promising in producing a variety of products, including food, feed supplements, chemicals, and biofuels. Medicinal supplements derived from microalgae are of a significant market in which compounds such as -carotene, astaxanthin, polyunsaturated fatty acids (PUFA) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and polysaccharides such as “glucan, are prominent. Microalgae species that are commonly applied for commercial productions include Isochrysis sp., Chaetoceros (Chlorella sp.), Arthrospira sp. (Spirulina Bioactive), and many more. In this present review, microalgae species that are feasible in metabolite production are summarized. Metabolites produced by microalgae as well as their prospective applications in the healthcare and pharmaceutical industries are comprehensively discussed. This evaluation is greatly assisting industrial stakeholders, investors, and researchers in making business decisions, investing in ventures, and moving the production of microalgae-based metabolites forward.
first_indexed 2025-11-15T13:55:16Z
format Article
id upm-106890
institution Universiti Putra Malaysia
institution_category Local University
last_indexed 2025-11-15T13:55:16Z
publishDate 2023
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling upm-1068902024-08-08T02:43:42Z http://psasir.upm.edu.my/id/eprint/106890/ Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review Tengku Ibrahim, Tengku Nilam Baizura Feisal, Nur Azalina Suzianti Kamaludin, Noor Haziqah Cheah, Wai Yan How, Vivien Bhatnagar, Amit Ma, Zengling Show, Pau Loke Microalgae are photoautotrophic microorganisms that comprise species from several phyla. Microalgae are promising in producing a variety of products, including food, feed supplements, chemicals, and biofuels. Medicinal supplements derived from microalgae are of a significant market in which compounds such as -carotene, astaxanthin, polyunsaturated fatty acids (PUFA) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and polysaccharides such as “glucan, are prominent. Microalgae species that are commonly applied for commercial productions include Isochrysis sp., Chaetoceros (Chlorella sp.), Arthrospira sp. (Spirulina Bioactive), and many more. In this present review, microalgae species that are feasible in metabolite production are summarized. Metabolites produced by microalgae as well as their prospective applications in the healthcare and pharmaceutical industries are comprehensively discussed. This evaluation is greatly assisting industrial stakeholders, investors, and researchers in making business decisions, investing in ventures, and moving the production of microalgae-based metabolites forward. Elsevier 2023 Article PeerReviewed Tengku Ibrahim, Tengku Nilam Baizura and Feisal, Nur Azalina Suzianti and Kamaludin, Noor Haziqah and Cheah, Wai Yan and How, Vivien and Bhatnagar, Amit and Ma, Zengling and Show, Pau Loke (2023) Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review. Bioresource Technology, 372. pp. 1-14. ISSN 0960-8524; ESSN: 1873-2976 https://linkinghub.elsevier.com/retrieve/pii/S0960852423000871 10.1016/j.biortech.2023.128661
spellingShingle Tengku Ibrahim, Tengku Nilam Baizura
Feisal, Nur Azalina Suzianti
Kamaludin, Noor Haziqah
Cheah, Wai Yan
How, Vivien
Bhatnagar, Amit
Ma, Zengling
Show, Pau Loke
Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review
title Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review
title_full Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review
title_fullStr Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review
title_full_unstemmed Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review
title_short Biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review
title_sort biological active metabolites from microalgae for healthcare and pharmaceutical industries: a comprehensive review
url http://psasir.upm.edu.my/id/eprint/106890/
http://psasir.upm.edu.my/id/eprint/106890/
http://psasir.upm.edu.my/id/eprint/106890/